Anavex Life Sciences to Present at the H.C. Wainwright Global Life Sciences ConferenceGlobeNewsWire • 03/04/21
Top Wall Street analysts say buy stocks like Denny's and Cloudflare as economy reopensCNBC • 02/21/21
Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021GlobeNewsWire • 02/18/21
Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/12/21
Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business OutlookGlobeNewsWire • 02/11/21
Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021GlobeNewsWire • 02/08/21
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect ConferenceGlobeNewsWire • 01/06/21
Anavex Life Sciences Corp. (AVXL) CEO Dr. Christopher Missling on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 12/29/20
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program UpdatesGlobeNewsWire • 12/28/20
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020GlobeNewsWire • 12/22/20
Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data hosted by Ladenburg Thalmann & Co.GlobeNewsWire • 12/21/20
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett SyndromeGlobeNewsWire • 12/15/20
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application with Expanding Claims Covering ANAVEX®2-73 (blarcamesine) for the Treatment of Rett Syndrome and other Neurodevelopmental DisordersGlobeNewsWire • 11/30/20
Anavex Life Sciences to Present at the Evercore ISI 3rd Annual HealthCONx ConferenceGlobeNewsWire • 11/25/20
Proof of Concept Controlled Phase 2 Clinical Trial Data Evaluating ANAVEX®2-73 (blarcamesine) in Parkinson's Disease Dementia Presented at CTAD 2020 ConferenceGlobeNewsWire • 11/06/20